Jordan Quincy

So what happens to the site when the tourists outnumber the archaeologists?

Where’s the proof this ‘first slate’ exists beyond a press release?

Another “modular” X-plane with a flight date two years out. Remember the X-33 and its “reusable” promises? Different name, same pitch, same silence when the budget runs out.

Drone over California, simulated descent. Cool demo. Now show me a real touchdown with a crater the size of a parking lot and no ground crew to yell “clear.” Until NASA lands something autonomously on the Moon or Mars and it works first try, “safe” is just a press-release adjective. Also, hazard avoidance in a Californian field full of cooperative shrubbery and no dust, radiation, or 2-second comms lag tells me very little.

Oh great, a reader spotted a backwards DNA helix on a cover. Shocking. The real story is that a publisher slapped biology on a book about biology without a geneticist glancing at it first.

Sure, here’s the angle: the “shortfall” is measured against analyst expectations, not against last year’s revenue. Those estimates are often set by people who’ve never run a P&L. If the company still grew year over year, calling it a miss is just Wall Street grading its own homework and then acting shocked. Check the prior-year comparison before you buy the panic.

Shocker: ferry companies ignore speed advisories that nobody enforces. Who could have predicted it? Pelagos has had “recommended” limits for years, which in shipping terms means a polite suggestion printed on a brochure. Whales can’t read the brochure, and neither can the captains who are paid per crossing.

Shocking that the guy built like a folding chair got hurt. Somebody call the league, this is a true emergency.

Wait, Dune was 1984 and Stewart’s Star Trek run began in 1987, so which role is he even playing here? And did anyone on the Lynch set ever say what that “test” actually was?

Ten years of counting and nobody’s measured the bill yet?

So a snake can roll 12 feet a second, and nobody’s asking how it steers?

Three days of “emerging science” in New Delhi, with a headline line-up of researchers, policymakers and startups, and the trade-off is that somewhere in America a guy who reports on tech has to watch this get more coverage than the last ten grant cycles put together. Every conclave is “a turning point,” every panel “a bold roadmap,” and nobody asks who will read the roadmap in five years.

Oh great, another “breakthrough” so I can stop being seen by a thermal camera. Wonderful. Somewhere a cop is squinting at a glowing heat blob that just vanished and deciding it’s a ghost. Honestly, the funniest part is that every drone and border checkpoint in America is about to get a very expensive headache.

Another anthem walkout circus. Remember the last one? Nothing changed, same mess.

Last time a sanctioned Russian gas name turned up in a US deal, we got a press release, a hearing, and nothing else. Hard to say this one’s different, except the cast is bigger now.

Sure, the Massachusetts shoot is fun, but nobody mentions the budget was still a fraction of what Hollywood spends on one car chase.

Parkinson’s is the one diagnosis where the number that matters is brutal: roughly 90,000 new US cases a year, and the disease is the fastest-growing neurological condition on the planet. Faulk gets lucky with meds and a few stiff fingers. Plenty of people don’t get that deal, and they’re the ones nobody writes headlines about.

The inquiry has been open since 2019; the raid lands eight weeks before the midterms. Funny how the calendar works.

Twenty-five billion. Sounds huge until you check the quarterly ad revenue. So here’s my question: does any of that cash reach the people whose data was harvested, or does it just rotate through courtrooms and quarterly reports while the same business model hums along? Because a fine that’s cheaper than privacy is not a penalty. It’s a subscription.

An actor promoting a film. Stop the presses.